Combination therapy for treatment or prevention of atherosclerosis.
Kwang Kon
KK
Koh
Michael J
MJ
Quon
D050197:Atherosclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000175:diagnosis; D004359:Drug Therapy, Combination; D005260:Female; D011345:Fenofibrate / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000209:etiology; D008297:Male; D000077205:Pioglitazone; D018570:Risk Assessment; D012720:Severity of Illness Index; D013777:Tetrazoles / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use; D016896:Treatment Outcome
D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D045162:Thiazolidinediones; C081643:candesartan; D011345:Fenofibrate; D000077205:Pioglitazone